SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
ALK-Abelló A/S (AKABY) trades at a trailing P/E of 450.0. Trailing earnings yield is 0.22%. PEG 0.58 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 450.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.22%).
- PEG Ratio 0.58 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 0.22% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 59/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AKABY
Valuation Multiples
P/E (TTM)450.0
Forward P/EN/A
PEG Ratio0.58
Forward PEGN/A
P/B Ratio0.00
P/S Ratio25.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.20
Book Value / Share$0.00
Revenue / Share$3.56
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.22%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$0.21 |
$2.35B |
$209M |
8.9% |
| 2013 |
$0.06 |
$2.24B |
$61M |
2.7% |
| 2014 |
$0.18 |
$2.43B |
$181M |
7.4% |
| 2015 |
$0.35 |
$2.57B |
$344M |
13.4% |
| 2016 |
$0.27 |
$3.01B |
$270M |
9% |
| 2017 |
$-0.16 |
$2.91B |
$-158M |
-5.4% |
| 2018 |
$-0.16 |
$2.92B |
$-170M |
-5.8% |
| 2019 |
$-0.05 |
$3.27B |
$-50M |
-1.5% |
| 2020 |
$0.02 |
$3.49B |
$25M |
0.7% |
| 2021 |
$0.20 |
$3.92B |
$219M |
5.6% |
